FDA set to grant full approval to Pfizer vaccine without public discussion of data

BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n2086  (Published 20 August 2021)Cite this as: BMJ 2021;374:n2086 Article Related content Metrics Responses Gareth Iacobucci Transparency advocates have criticised the US Food and Drug Administration’s (FDA) decision not to hold a formal advisory committee meeting to discuss Pfizer’s application for full approval of its covid-19 vaccine. Last year the FDA said it was “committed to useContinue reading “FDA set to grant full approval to Pfizer vaccine without public discussion of data”